Article
Genetics of diffuse large B-cell lymphoma.
Blood - 24 May 2018
Pasqualucci Laura, Dalla-Favera Riccardo
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL), the most frequent subtype of lymphoid malignancy, remains a significant clinical challenge, as ∼30% of patients are not cured. Over the past decade, remarkable progress has been made in the understanding of the pathogenesis of this disease, spurred by the implementation of powerful genomic technologies that enabled the definition of its genetic and epigenetic landscape....
Topics
Join the communities discussing this publication.